Company intelligence / Profile preview

Mantis Photonics

Lund, Skåne, Swedenmantis-photonics.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Mantis Photonics has developed and patented a hyperspectral retinal imaging camera capable of detecting biomarkers such as amyloid beta for early diagnosis of Alzheimer’s disease. The technology is in early-stage development with core technology tested and proof-of-concept established; clinical validation across multiple indications is ongoing or planned.

Therapeutic areas: OphthalmologyCardiovascularNeurology
Modalities: DeviceDiagnostic imaging platform (hyperspectral camera)
Industry: Medical Imaging

Partnerships

ESA BIC Sweden incubator program/grant supportLund University/LU Holding

Beyond the preview

Go deeper on Mantis Photonics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mantis Photonics.

Explore the full profile